Allarity Therapeutics, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of units for the quarter ending 2023-06-30 was $812.00K, a 404.35% increase year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of units for the quarter ending 2023-03-31 was $2.00K, a 99.56% decline year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of units for the quarter ending 2022-09-30 was $341.00K.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of units for the quarter ending 2022-06-30 was $161.00K.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of units for fiscal 2022 was $954.00K, a 1172.00% increase from fiscal 2021.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of units for fiscal 2021 was $75.00K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2023-06-30 | $812.00K 10-Q · filed 2024-08-05 | |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $954.00K 10-K · filed 2023-03-13 | |
| 2022-09-30 | $341.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $161.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $452.00K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $75.00K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |